• July 27, 2007

    Instructor, Pilot Get $53M For Florida Plane Crash

    Eight years after a plane crash severely injured a Floridian flight instructor and his student, the two men on Thursday won a $53 million jury award against the makers of the airplane, which was found to have a defective carburetor.

  • July 27, 2007

    WaMu Fails In Attempt To Kill State Claims

    A judge on Thursday denied Washington Mutual Inc.’s request to dismiss state law claims in a proposed FLSA class action brought on behalf of loan consultants, ruling that the legal doctrine cited by the bank in its motion to dismiss for violation of the Rules Enabling Act was “imaginary.”

  • July 27, 2007

    EPA Gets More Heat Over California Emissions Cap

    The U.S. Environmental Policy Administration should stop dragging its feet in deciding whether to allow California to regulate greenhouse gas emissions and take action soon, Democrats have told the agency's chief.

  • July 26, 2007

    Man Injured By Ford Van Wins $6M

    A Florida jury on Wednesday ordered Ford Motor Co. to pay $6 million to a 22-year-old man who was temporarily paralyzed in the rollover of a 1993 Ford Aerostar van five years ago.

  • July 26, 2007

    Ex-Mutual Benefits President To Pay Investors

    The former president of Mutual Benefits Corp., who has been sentenced earlier this year to serve 20 years behind bars for securities fraud, has agreed to settle a lawsuit brought by investors for at least $1.5 million.

  • July 27, 2007

    Judge Orders Mediation In Drug Pricing Suit

    In a bid to bring some closure to a massive antitrust class action alleging a slew of drug makers defrauded consumers by artificially inflating the prices of various prescription medications, a federal judge has ordered certain parties in the case to resolve their differences through mediation.

  • July 25, 2007

    Judge Allows Pharmanet Derivative Suit To Continue

    A New Jersey federal judge has refused to throw out a derivative lawsuit filed against directors of drug testing firm Pharmanet Development Group Inc. on grounds of demand futility, ruling that the directors would not have been biased in considering the shareholders' demands.

  • July 25, 2007

    States Bury Hatchet With TAP Over Drug Pricing

    In a boost for TAP Pharmaceutical Products Inc., the states of Montana and Nevada have asked a federal judge to sign off on a settlement that would toss the company from a massive antitrust class action alleging that a spate of drug makers defrauded consumers by artificially inflating the prices of various prescription medications.

  • July 25, 2007

    EU Sends Letters Alleging Banana Conspiracy

    The European Commission has charged Chiquita Brands International Inc., Ireland's Fyffes Plc, Fresh Del Monte Inc., Dole Food Company Inc., and Ecuador's Exportadora Bananera Noboa with conspiring to fix the price of bananas, sending the companies formal statements of objection.

  • July 24, 2007

    Jewish Mother Wins Discrimination Suit Against VA

    A jury has ordered the increasingly beleaguered U.S. Department of Veterans Affairs to fork over $300,000 to a former pharmacist who sued it for religious discrimination.

  • July 23, 2007

    Hedge Funds Plead Guilty To $195M Scam

    Three hedge funds on Friday pled guilty for their parts in a conspiracy that cost more than 250 investors nearly $195 million over the course of five years.

  • July 23, 2007

    Judge Tosses Some Accutane IBD Cases

    A judge has dismissed the cases that relied on the testimony of a doctor to prove allegations that taking Roche Holding AG's acne drug Accutane gave them irritable bowel disease.

  • July 20, 2007

    800 Adept Pushes Back Against Stay Request

    The four largest U.S. mobile carriers and a telephone routing company, embroiled in a dispute over patents for the routing of emergency 911 calls, continue to battle over whether their case should be stayed until an appellate court issues its ruling on a related matter.

  • July 20, 2007

    Abbott Gets Third-Party Subpoenas Quashed

    Abbott Laboratories Inc., which stands accused of publishing inflated average wholesale prices for its drugs, won a victory Thursday when a judge acceded to its request to quash subpoenas that the federal government had served on former Abbott customers.

  • July 19, 2007

    Credit Card Cos. Hit With Prepaid Card Patent Suit

    A Florida-based patent-holding company has filed a patent infringement lawsuit against credit card companies American Express Co., Mastercard Inc. and Visa USA Inc. for allegedly violating patents related to prepaid gift cards.

  • July 18, 2007

    All American's Creditors Want To Hold On To Leases

    The unsecured creditors of All American Semiconductor Inc. on Tuesday objected to the company’s motions to reject certain real property and equipment leases, arguing that holding on to the leases may benefit the estate.

  • July 18, 2007

    Abbott Bids To Toss New Government Claims

    Abbott Laboratories, one of a slew of pharmaceutical makers involved in a massive antitrust class action alleging the companies defrauded consumers by artificially inflating the prices for various prescription drugs, has moved to dismiss fresh claims brought by government authorities.

  • July 18, 2007

    More Plead Guilty In Securities Scam

    Three people affiliated with defunct viatical and life settlement company Mutual Benefits Corp. have pled guilty for their role in defrauding investors out of nearly $1 billion.

  • July 17, 2007

    Technicians Hit CVS With FLSA Suit

    A group of pharmacy technicians has hit CVS/Caremark Corp. with a collective action, accusing the national drugstore chain of engaging in such illegal practices as failing to pay overtime and refusing to compensate employees for breaks not taken.

  • July 17, 2007

    Universal Express Fights SEC's Moves To Drop Claims

    A transportation company fined $22 million for illegally distributing shares is fighting moves by the U.S. Securities and Exchange Commission to drop six claims against it without legal prejudice, saying the regulator shouldn't “have it both ways.”